共 224 条
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
被引:45
作者:
Baptista, Abrahao Fontes
[1
,2
,3
,4
]
Baltar, Adriana
[2
,5
]
Okano, Alexandre Hideki
[1
,2
,3
,6
]
Moreira, Alexandre
[7
]
Campos, Ana Carolina Pinheiro
[8
]
Fernandes, Ana Mercia
[9
]
Brunoni, Andre Russowsky
[10
,11
]
Badran, Bashar W.
[12
]
Tanaka, Clarice
[2
,13
]
de Andrade, Daniel Ciampi
[2
,9
]
da Silva Machado, Daniel Gomes
[14
]
Morya, Edgard
[15
]
Trujillo, Eduardo
[1
,2
]
Swami, Jaiti K.
[16
]
Camprodon, Joan A.
[17
,18
]
Monte-Silva, Katia
[2
,19
]
Sa, Katia Nunes
[2
,20
,21
]
Nunes, Isadora
[21
]
Goulardins, Juliana Barbosa
[2
,4
,7
,22
]
Bikson, Marom
[16
]
Sudbrack-Oliveira, Pedro
[23
]
de Carvalho, Priscila
[13
]
Duarte-Moreira, Rafael Jardim
[1
,2
]
Pagano, Rosana Lima
[8
]
Shinjo, Samuel Katsuyuki
[24
]
Zana, Yossi
[1
]
机构:
[1] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, Brazil
[2] NAPeN Network Rede Nucleos Assistencia & Pesquisa, Sao Bernardo Do Campo, Brazil
[3] Univ Estadual Campinas, Brazilian Inst Neurosci & Neurotechnol, Ctr Pesquisa Invest & Difusao, Fundacao Amparo Pesquisa Estado Sao Paulo BRAINN, Campinas, Brazil
[4] Univ Sao Paulo, Lab Med Invest 54 LIM 54, Sao Paulo, Brazil
[5] Specialized Neuromodulat Ctr Neuromod, Recife, PE, Brazil
[6] Univ Estadual Londrina, Grad Program Phys Educ, Londrina, Parana, Brazil
[7] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
[8] Hosp Sirio Libanes, Lab Neurosci, Sao Paulo, Brazil
[9] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Ctr Dor,LIM62, Sao Paulo, Brazil
[10] Inst Nacl Biomarcadores Neuropsiquiatria, Lab Neurociencias LIM 27, Serv Interdisciplinar Neuromodulacao, Sao Paulo, Brazil
[11] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Psiquiatria, Sao Paulo, Brazil
[12] Med Univ South Carolina, Dept Psychiat, Charleston, SC 29425 USA
[13] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Cent, Sao Paulo, Brazil
[14] Univ Fed Rio Grande do Norte, Grad Program Collect Hlth, Natal, RN, Brazil
[15] Santos Dumont Inst, Edmond & Lily Safra Int Neurosci Inst, Macaiba, Brazil
[16] CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10031 USA
[17] Massachusetts Gen Hosp, Lab Neuropsychiat & Neuromodulat, Boston, MA 02114 USA
[18] Harvard Med Sch, Boston, MA 02115 USA
[19] Univ Fed Pernambuco, Appl Neurosci Lab, Recife, PE, Brazil
[20] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil
[21] Pontificia Univ Catolica Minas Gerais, Dept Physiotherapy, Betim, Brazil
[22] Univ Cruzeiro Sul UNICSUL, Sao Paulo, Brazil
[23] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo, Brazil
[24] Univ Sao Paulo, Fac Med FMUSP, Div Rheumatol, Sao Paulo, Brazil
基金:
巴西圣保罗研究基金会;
美国国家卫生研究院;
关键词:
coronavirus;
COVID-19;
non-invasive vagus nerve stimulation;
taVNS;
tDCS;
TMS;
neuromodulation;
NIBS;
DIRECT-CURRENT STIMULATION;
VAGUS NERVE-STIMULATION;
ACUTE RESPIRATORY SYNDROME;
HEART-RATE-VARIABILITY;
TRANSCRANIAL MAGNETIC STIMULATION;
SYNDROME CORONAVIRUS INFECTION;
NEURAL CELL-LINES;
IMMUNE-SYSTEM;
INFLAMMATORY MARKERS;
PERSISTENT INFECTION;
D O I:
10.3389/fneur.2020.573718
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
100204 [神经病学];
摘要:
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders. Methods: We summarize COVID-19 pathophysiology with emphasis of direct neuroinvasiveness, neuroimmune response and inflammation, autonomic balance and neurological, musculoskeletal and neuropsychiatric sequela. This supports the development of a framework for advancing applications of non-invasive neuromodulation in the management COVID-19 and related disorders. Results: Non-invasive neuromodulation may manage disorders associated with COVID-19 through four pathways: (1) Direct infection mitigation through the stimulation of regions involved in the regulation of systemic anti-inflammatory responses and/or autonomic responses and prevention of neuroinflammation and recovery of respiration; (2) Amelioration of COVID-19 symptoms of musculoskeletal pain and systemic fatigue; (3) Augmenting cognitive and physical rehabilitation following critical illness; and (4) Treating outbreak-related mental distress including neurological and psychiatric disorders exacerbated by surrounding psychosocial stressors related to COVID-19. The selection of the appropriate techniques will depend on the identified target treatment pathway. Conclusion: COVID-19 infection results in a myriad of acute and chronic symptoms, both directly associated with respiratory distress (e.g., rehabilitation) or of yet-to-be-determined etiology (e.g., fatigue). Non-invasive neuromodulation is a toolbox of techniques that based on targeted pathways and empirical evidence (largely in non-COVID-19 patients) can be investigated in the management of patients with COVID-19.
引用
收藏
页数:18
相关论文

